fenofibrate has been researched along with Brain Vascular Disorders in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Excerpt | Relevance | Reference |
---|---|---|
"Pretreatment by simvastatin and fenofibrate prevented CPB-induced endothelial dysfunction." | 1.43 | Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass. ( Amr, G; Azzaoui, R; Bordet, R; Delassus, L; Fossaert, E; Modine, T; Ouk, T; Tailleux, A, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitajima, S | 1 |
Furuichi, K | 1 |
Wada, T | 1 |
Ouk, T | 1 |
Amr, G | 1 |
Azzaoui, R | 1 |
Delassus, L | 1 |
Fossaert, E | 1 |
Tailleux, A | 1 |
Bordet, R | 1 |
Modine, T | 1 |
1 review available for fenofibrate and Brain Vascular Disorders
Article | Year |
---|---|
[Impact of dyslipidemia on the onset and progression of diabetic complications].
Topics: Cerebrovascular Disorders; Coronary Disease; Diabetic Angiopathies; Diabetic Nephropathies; Dyslipid | 2013 |
1 other study available for fenofibrate and Brain Vascular Disorders
Article | Year |
---|---|
Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.
Topics: Animals; Avoidance Learning; Cardiopulmonary Bypass; Cerebrovascular Disorders; Cognition Disorders; | 2016 |